Gainers

• Femasys FEMY shares moved upwards by 56.8% to $0.52 during Monday's after-market session. This security traded at a volume of 461.0K shares come close, making up 12.7% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
• Pliant Therapeutics PLRX stock rose 15.85% to $16.89. The company's market cap stands at $1.0 billion.
• Ontrak OTRK stock moved upwards by 10.45% to $0.95. The company's market cap stands at $4.6 million.
• Brainstorm Cell BCLI stock moved upwards by 9.42% to $0.47. This security traded at a volume of 566.4K shares come close, making up 202.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $21.0 million.
• 180 Life Sciences ATNF shares moved upwards by 8.65% to $0.65. The company's market cap stands at $3.8 million.
• Matinas BioPharma Hldgs MTNB stock moved upwards by 7.84% to $0.13. The company's market cap stands at $29.2 million.

Losers

• TransCode Therapeutics RNAZ stock declined by 20.0% to $2.04 during Monday's after-market session. This security traded at a volume of 15.7 million shares come close, making up 2625.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.1 million.
• Biophytis BPTS stock fell 8.18% to $1.46. At the close, Biophytis's trading volume reached 6.6 million shares. This is 1490.8% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
• NeuBase Therapeutics NBSE stock decreased by 7.69% to $0.79. The market value of their outstanding shares is at $2.9 million.
• Tivic Health Systems TIVC stock fell 5.48% to $1.9. The company's market cap stands at $2.7 million.
• Immix Biopharma IMMX stock decreased by 5.44% to $2.8. The company's market cap stands at $45.5 million.
• Inozyme Pharma INZY shares decreased by 4.88% to $4.1. The company's market cap stands at $253.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.